Home News NAFDAC Warns Against Circulation of Falsified Antimalarial, Antibiotic Drugs

NAFDAC Warns Against Circulation of Falsified Antimalarial, Antibiotic Drugs

0
NAFDAC Warns Against Circulation of Falsified Antimalarial, Antibiotic Drugs

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert (No. 030/2025) warning Nigerians about the circulation of confirmed substandard and falsified medicines in the country.

According to the agency, the affected products are ARTEMETRIN DS and CIPROFIT 500, both reportedly in circulation in Nigeria.

NAFDAC explained that ARTEMETRIN DS (Artemether/Lumefantrine) tablet (80mg/480mg) is labelled as manufactured by A.C. DRUGS Ltd, Plot C5/C6 Old Airport Road, Emene, Enugu State, while CIPROFIT 500 (Ciprofloxacin Tablet USP 500mg) is labelled as manufactured by Impact Pharmaceutical Ltd, No. 33A/33B Standard Industrial Layout, Emene, Enugu State.

The products were first tested using Thin-Layer Chromatography (TLC), which showed irregularities, prompting further analysis at a WHO-prequalified laboratory.

The High-Performance Liquid Chromatography (HPLC) assay confirmed that:

ARTEMETRIN DS contained only 59.2% Artemether and 71.2% Lumefantrine, far below the acceptable 90–110% range.

CIPROFIT 500 contained just 5.7% Ciprofloxacin, also below the required 90–110% limits.

The agency stressed that the products were purchased from a licensed vendor and wholesaler but do not appear on NAFDAC’s registered products database. It also revealed that the NAFDAC Registration Numbers displayed on both products are fake.

NAFDAC urged Nigerians to exercise caution:

> “If you possess any of the products listed above, stop selling or using them immediately and return your stock to the nearest NAFDAC office. If you or someone you know has used any of these products and experienced adverse reactions, seek immediate medical attention from a qualified healthcare professional,” the agency warned.